| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 9e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |